Rob Sobhani
PhD
Chief Executive Officer
👥Biography 个人简介
Rob Sobhani leads Champions Oncology, a company that has commercialized organoid-based drug sensitivity testing as a clinical service for oncologists seeking personalized treatment guidance. His TumorGraft and 3D organoid platforms have been validated across thousands of patient tumors, demonstrating clinical utility in guiding therapy selection. He has driven the regulatory and commercial pathway for organoid diagnostics in precision oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Rob Sobhani 的研究动态
Follow Rob Sobhani's research updates
留下邮箱，当我们发布与 Rob Sobhani（Champions Oncology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment